JP Morgan Chase’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-85,000
Closed -$1.21M 7474
2025
Q2
$1.21M Hold
85,000
﹤0.01% 4257
2025
Q1
$893K Sell
85,000
-220,500
-72% -$2.49M ﹤0.01% 4429
2024
Q4
$3.7M Buy
+305,500
New +$4M ﹤0.01% 3631
2024
Q2
Sell
-734,700
Closed -$12M 7440
2024
Q1
$12M Sell
734,700
-679,500
-48% -$10.6M ﹤0.01% 2328
2023
Q4
$21.1M Buy
+1,414,200
New +$16M ﹤0.01% 1817
2022
Q4
Sell
-402,000
Closed -$4.99M 6647
2022
Q3
$4.99M Buy
+402,000
New +$7.03M ﹤0.01% 2741
2021
Q2
Sell
-150,000
Closed -$4.42M 6406
2021
Q1
$4.42M Hold
150,000
﹤0.01% 3077
2020
Q4
$4.6M Buy
150,000
+130,600
+673% +$3.98M ﹤0.01% 2877
2020
Q3
$519K Buy
+19,400
New +$492K ﹤0.01% 3969
2020
Q2
Sell
-33,100
Closed -$741K 5450
2020
Q1
$741K Sell
33,100
-22,200
-40% -$608K ﹤0.01% 3608
2019
Q4
$1.63M Buy
55,300
+50,600
+1,077% +$1.37M ﹤0.01% 3533
2019
Q3
$125K Buy
+4,700
New +$141K ﹤0.01% 4817

Other funds holding ELAN

JP Morgan Chase's ELAN Position: Q1 2026 in Review

JP Morgan Chase increased its Elanco Animal Health (ELAN) stake by 7.8% in Q1 2026, buying an estimated $3.44M and bringing the position to 1,954,888 shares worth $45.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

JP Morgan Chase first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $218M in Q2 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • JP Morgan Chase held 1,954,888 shares of Elanco Animal Health worth $45.8M as of Q1 2026.
  • JP Morgan Chase bought 140,745 Elanco Animal Health shares in Q1 2026, an estimated $3.44M.
  • Elanco Animal Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1449 holding.
  • JP Morgan Chase first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Elanco Animal Health position peaked at $218M in Q2 2019.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.